Germany
-
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Phase 2 · randomised · 1,109 people · 47 sites in 8 countries · Recruiting now
-
A Clinical Study of Arfolitixorin in Patients With mCRC
Phase 2 · randomised · 90 people · 3 sites in Germany · Recruiting now
-
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
Phase 2 · randomised · 327 people · 86 sites in 7 countries · Running, not taking new patients
-
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Phase 3 · randomised · 712 people · 1,049 sites in 3 countries · Running, not taking new patients
-
Safety of HRX215 in Patients After Minor and Major Liver Resection
Phase 2 · randomised · 80 people · 12 sites in 5 countries · Recruiting now